Which patients with bipolar depression receive antidepressant augmentation? Results from an observational multicenter study.

Laura MusettiAntonio TundoErika Cambiali Claudia Del GrandeRocco De FilippisCaterina FranceschiniLuca ProiettiSophia BetròDonatella MarazzitiLiliana Dell'Osso

Published in: CNS spectrums (2021)

Our findings indicate that ADs, combined with MS and/or SGA, are short and long term effective and safe in a specific subgroup for bipolar depressed patients.

Keyphrases

end stage renal disease
bipolar disorder
newly diagnosed
ejection fraction
chronic kidney disease
major depressive disorder
mass spectrometry
peritoneal dialysis
multiple sclerosis
ms ms
randomized controlled trial
clinical trial
sleep quality
patient reported outcomes
physical activity